Home/Filings/4/0001610717-24-000044
4//SEC Filing

Wahlstrom Mats 4

Accession 0001610717-24-000044

CIK 0001512762other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:03 PM ET

Size

10.1 KB

Accession

0001610717-24-000044

Insider Transaction Report

Form 4
Period: 2024-02-01
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-01$1.67/sh+44,991$75,00099,988 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-0144,9910 total
    Exercise: $1.67Exp: 2024-03-10Common Stock (44,991 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-0114,9970 total
    Exercise: $1.67Exp: 2024-03-10Common Stock (14,997 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-01$1.67/sh+14,997$25,00054,997 total
Footnotes (2)
  • [F1]This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.
  • [F2]The option is fully vested and exercisable.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001459154

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:03 PM ET
Size
10.1 KB